
|Articles|May 22, 2014
Pharm Exec's Brands of Yesteryear: Where Are They Now?
Author(s)Ben Comer
Pharm Exec’s Brand of the Year selections from the last few years are still alive and kicking, although some have aged more gracefully than others.
Advertisement
Pharm Exec’s Brand of the Year selections from the last few years are still alive and kicking, although some have aged more gracefully than others.
The US drug pricing wars may be coming, but these products already made their mint. We checked back in with them to see how things are going, and to look for indicators about their future prospects.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5




